BMO raises Corteva stock price target to $100 on EBITDA outlook

BMO Capital has increased its price target for Corteva Inc. (NYSE:CTVA) to $100 from $95, maintaining an Outperform rating, based on a raised 2027 EBITDA estimate of $4.5 billion. This adjustment comes despite a recent stock decline, with BMO believing the market reaction to the company's Q2 results was overdone given a guidance increase. The firm remains optimistic about Corteva's future, especially ahead of an October 1 separation, citing improved agricultural dynamics and pipeline opportunities.